IP Library Granted Patent US 8,093,379
Granted Patent B2
US 8,093,379 · App. 12/563,072 · Granted Jan 10, 2012

Macrocyclic serine protease inhibitors

Assignee: Idenix Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,093,379
App. No.
12/563,072
Granted
Jan 10, 2012
Kind
B2
Abstract

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

Claims (65)

1. A method of preparing compound 129a having a structure of:

which comprises the steps of:

(a) reacting compound 127a having a structure of:

with CDI to form compound 128a having a structure of:

(b) coupling compound 128a with compound 128b having a structure of:

to form compound 129a;

wherein:

R 6 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl;

R 8 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, C 1-6 alkyl-C 3-7 cycloalkylene, —CH 2 NR 8a R 8b , —CH(R 8c )NR 8a R 8b , —CHR 8c CHR 8d NR 8a R 8b , or —CH 2 CR 8c R 8d NR 8a R 8b , wherein:

each R 8a , R 8c , and R 8d is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, or C 6-14 aryl-C 1-6 alkylene; and

each R 8b is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, —S(O) k R 11 , —S(O) k NR 11 R 12 , —C(O)R 11 , —C(O)OR 11 , —C(O)NR 11 R 12 , or —C(═NR 13 )NR 11 R 12 ; wherein each R 11 , R 12 , and R 13 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or R 11 and R 12 together with the N atom to which they are attached form heterocyclyl; or

R 8a and R 8b together with the N atom to which they are attached form heterocyclyl;

R 17 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl;

L is a bond, C 1-6 alkylene, C 3-7 cycloalkylene, C 2-6 alkenylene, C 2-6 alkynylene, X, or —(CR 6a R 6b ) p X—; wherein p is an integer of 1, 2, or 3; R 6a and R 6b are each independently hydrogen, halo, cyano, hydroxyl, or alkoxy; and X is —O—, —C(O)—, —C(O)O—, —OC(O)O—, —C(O)NR 14 —, —NR 14 —, —NR 14 C(O)NR 15 —, —C(═NR 14 )NR 15 —, —NR 14 C(═NR 15 )NR 16 —, —S(O) k —, —S(O) k NR 14 —, —NR 14 S(O) k NR 15 —, —P(O)(OR 14 )—, or —OP(O)(OR 14 )—, where each R 14 , R 15 , and R 16 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; and each k is independently an integer of 1 or 2; and

n is an integer of 0, 1, 2, 3, 4, or 5;

wherein each alkyl, alkylene, alkenyl, alkenylene, alkynyl, alkynylene, aryl, cycloalkyl, cycloalkylene, heterocyclyl, and heteroaryl is optionally substituted with one or more groups, each independently selected from cyano, halo, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q;

wherein each Q is independently selected from the group consisting of cyano, halo, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or —C(O)R e , —C(O)OR e , —C(O)NR f R g , —C(NR e )NR f R g , —OR e , —OC(O)R e , —OC(O)OR e , —OC(O)NR f R g , —OC(═NR e )NR f R g , —OS(O)R e , —OS(O) 2 R e , —OS(O)NR f R g , —OS(O) 2 NR f R g , —NR f R g , —NR e C(O)R f , —NR e C(O)OR f , —NR e C(O)NR f R g , —NR e C(═NR h )NR f R g , —NR e S(O)R f , —NR e S(O) 2 R f , —NR e S(O)NR f R g , —NR e S(O) 2 NR f R g , —SR e , —S(O)R e , or —S(O) 2 R e ; wherein each R e , R f , R g , and R h is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or R f and R g together with the N atom to which they are attached form heterocyclyl.

2. The method of claim 1 , wherein R 6 is selected from the group consisting of:

wherein:

each R 1′ , R 2′ , R 3′ , R 5′ , R 6′ , R 7′ , and R 8′ is independently:

hydrogen, halo, cyano, trifluoromethyl, or nitro;

C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or

—C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ;

wherein each R a , R b , R c , and R d is independently hydrogen; or C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q.

3. The method of claim 2 , wherein R 2 is selected from the group consisting of:

wherein

each A is independently hydrogen, halo, cyano, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q; and

each E is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ;

wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q.

4. The method of claim 2 , wherein R 2′ is selected from the group consisting of:

5. The method of claim 1 , wherein R 17 is hydrogen or methyl.

6. The method of claim 1 , wherein L is a bond or —O—.

7. The method of claim 1 , wherein n is 1, 2, or 3.

8. The method of claim 1 , wherein R 8 is methyl, cyclopropyl, 1-methylcyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl.

9. The method of claim 1 , wherein the compound 129a is

10. A method of preparing compound 7 having a structure of:

which comprises the step of contacting compound 129a having the structure of:

with a ring closure metathesis catalyst;

wherein:

R 6 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl;

R 8 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, C 1-6 alkyl-C 3-7 cycloalkylene, —CH 2 NR 8a R 8b , —CH(R 8c )NR 8a R 8b , —CHR 8c CHR 8d NR 8a R 8b , or —CH 2 CR 8c R 8d NR 8a R 8b , wherein:

each R 8a , R 8c , and R 8d is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, or C 6-14 aryl-C 1-6 alkylene; and

each R 8b is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, heterocyclyl, —S(O) k R 11 , —S(O) k NR 11 R 12 , —C(O)R 11 , —C(O)OR 11 , —C(O)NR 11 R 12 , or —C(═NR 13 )NR 11 R 12 ; wherein each R 11 , R 12 , and R 13 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or R 11 and R 12 together with the N atom to which they are attached form heterocyclyl; or

R 8a and R 8b together with the N atom to which they are attached form heterocyclyl;

R 17 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl;

L is a bond, C 1-6 alkylene, C 3-7 cycloalkylene, C 2-6 alkenylene, C 2-6 alkynylene, X, or —(CR 6a R 6b ) p X—; wherein p is an integer of 1, 2, or 3; R 6a and R 6b are each independently hydrogen, halo, cyano, hydroxyl, or alkoxy; and X is —O—, —C(O)—, —C(O)O—, —OC(O)O—, —C(O)NR 14 —, —NR 14 —, —NR 14 C(O)NR 15 —, —C(═NR 14 )NR 15 —, —NR 14 C(═NR 15 )NR 16 —, —S(O) k —, —S(O) k NR 14 —, —NR 14 S(O) k NR 15 , —P(O)(OR 14 )—, or —OP(O)(OR 14 )—, where each R 14 , R 15 , and R 16 is independently hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; and each k is independently an integer of 1 or 2; and

n is an integer of 0, 1, 2, 3, 4, or 5;

wherein each alkyl, alkylene, alkenyl, alkenylene, alkynyl, alkynylene, aryl, cycloalkyl, cycloalkylene, heterocyclyl, and heteroaryl is optionally substituted with one or more groups, each independently selected from cyano, halo, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more, in one embodiment, one, two, three, or four, substituents Q;

wherein each Q is independently selected from the group consisting of cyano, halo, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or —C(O)R e , —C(O)OR e , —C(O)NR f R g , —C(NR e )NR f R g , —OR e , —OC(O)R e , —OC(O)OR e , —OC(O)NR f R g , —OC(═NR e )NR f R g , —OS(O)R e , —OS(O) 2 R e , —OS(O)NR f R g , —OS(O) 2 NR f R g , —NR f R g , —NR e C(O)R f , —NR e C(O)OR f , —NR e C(O)NR f R g , —NR e C(═NR h )NR f R g , —NR e S(O)R f , —NR e S(O) 2 R f , —NR e S(O)NR f R g , —NR e S(O) 2 NR f R g , —SR e , —S(O)R e , or —S(O) 2 R e ; wherein each R e , R f , R g , and R h is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl; or R f and R g together with the N atom to which they are attached form heterocyclyl.

11. The method of claim 10 , wherein R 6 is selected from the group consisting of:

wherein:

each R 1′ , R 2′ , R 3′ , R 5′ , R 6′ , R 7′ , and R 8′ is independently:

hydrogen, halo, cyano, trifluoromethyl, or nitro;

C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or

C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; or C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q.

12. The method of claim 11 , wherein R is selected from the group consisting of:

wherein

each A is independently hydrogen, halo, cyano, or nitro; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O) 2 R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q; and

each E is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or —C(O)R a , —C(O)OR a , —C(O)NR b R c , —C(NR a )NR b R c , —OR a , —OC(O)R a , —OC(O)OR a , —OC(O)NR b R c , —OC(═NR a )NR b R c , —OS(O)R a , —OS(O) 2 R a , —OS(O)NR b R c , —OS(O) 2 NR b R c , —NR b R c , —NR a C(O)R b , —NR a C(O)OR b , —NR a C(O)NR b R c , —NR a C(═NR d )NR b R c , —NR a S(O)R b , —NR a S(O)R b , —NR a S(O)NR b R c , —NR a S(O) 2 NR b R c , —SR a , —S(O)R a , or —S(O) 2 R a ; wherein each R a , R b , R c , and R d is independently hydrogen; C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 6-14 aryl, heteroaryl, or heterocyclyl, each optionally substituted with one or more substituents Q; or R b and R c together with the N atom to which they are attached form heterocyclyl, optionally substituted with one or more substituents Q.

13. The method of claim 11 , wherein R 2 is selected from the group consisting of:

14. The method of claim 10 , wherein R 17 is hydrogen or methyl.

15. The method of claim 10 , wherein L is a bond or —O—.

16. The method of claim 10 , wherein n is 1, 2, or 3.

17. The method of claim 10 , wherein R 8 is methyl, cyclopropyl, 1-methylcyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl.

18. The method of claim 10 , wherein the compound 7 is

Assignments (2)
CHANGE OF NAME Recorded Jul 30, 2015
From: IDENIX PHARMACEUTICALS, INC.
To: IDENIX PHARMACEUTICALS LLC
Reel/Frame 036234/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2009
From: STEWART, ALISTAIR; ROSINOVSKY, ELODIE; MOUSSA, ADEL; MAYES, BENJAMIN ALEXANDER
To: IDENIX PHARMACEUTICALS, INC.
Reel/Frame 023398/0641 →
Continuity (4)
Continuation 12365127 · Feb 3, 2009
Provisional Application 61026086 · Feb 4, 2008
Provisional Application 61083867 · Jul 25, 2008
Related Publication 20100016578A1 · Jan 21, 2010